The efficiency of different combined treatment programs (combination chemotherapy-radiotherapy) used for stage I-II Hodgkin's disease (Q68974110)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3562890%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

title

The efficiency of different combined treatment programs (combination chemotherapy-radiotherapy) used for stage I-II Hodgkin's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3562890%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

author name string

G D Baysogolov

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3562890%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

S V Shakhtarina

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3562890%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

publication date

1 February 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3562890%20AND%20SRC:MED&resulttype=core&format=json

Radiotherapy and Oncology

28 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3562890%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3562890%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3562890%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

page(s)

113-122

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3562890%20AND%20SRC:MED&resulttype=core&format=json

Mantle Field Irradiation for Stages IA and IIA Hodgkin's Disease

28 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2887%2980164-0

7 January 2021

Chemotherapy--radiotherapy association in Hodgkin's disease, clinical stages IA, II2A: results of a prospective clinical trial with 166 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2887%2980164-0

7 January 2021

Complications of treatment encountered in lymphoma-leukemia long-term survivors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2887%2980164-0

7 January 2021

Risk of leukemia in patients treated for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2887%2980164-0

7 January 2021

Latent radiation injury of lungs or heart activated by steroid withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2887%2980164-0

7 January 2021

Hodgkin's Disease, Clinical Stages I and II Results of radical irradiation with or without chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2887%2980164-0

7 January 2021

Female Reproductive Potential after Treatment for Hodgkin's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2887%2980164-0

7 January 2021

Hodgkin's disease: the pendulum swings. Knox lecture, Royal College of Radiologists, 1977.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2887%2980164-0

7 January 2021

Experimental and Clinical Results of Chemotherapy after Partial Synchronization of Cell Proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2887%2980164-0

7 January 2021

Second malignant neoplasms in patients treated for hodgkin's disease with radiotherapy or radiotherapy and chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2887%2980164-0

7 January 2021

Radiotherapy versus radiotherapy plus chemotherapy in stages I and II Hodgkin's disease. A prospective, randomized study by the Danish National Hodgkin Study Group, LYGRA.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2887%2980164-0

7 January 2021

Long-term follow up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2887%2980164-0

7 January 2021

Possibilities of radiation-dose reduction in the treatment of Hodgkin's disease. I. Exclusion of the mediastinum from the radiation field in primary high-cervical or infradiaphragmatic involvement and stage I or II (author's transl)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2887%2980164-0

7 January 2021

Long-term results of the E.O.R.T.C. randomized study of irradiation and vinblastine in clinical stages I and II of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2887%2980164-0

7 January 2021

10.1016/S0167-8140(87)80164-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3562890%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

1 reference